Barbiturates and pyrazolopyridines for the treatment of postpartum depression—repurposing of two drug classes
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2023.1139889
Abstract: Zulresso (brexanolone) is an aqueous formulation of the neurosteroid, allopregnanolone, and the only FDA-approved medication for the treatment of postpartum depression (PPD). While brexanolone is effective for the treatment of PPD, lengthy infusion time and… read more here.
Keywords: postpartum depression; treatment postpartum; gabaa receptors; barbiturates pyrazolopyridines ... See more keywords